Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
Listening to the news is available in the app: AI-voice headlines, the daily bulletins and instant breaking-news alerts.